Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,23501,41,7.44 [1.37-40.56],0.0202984874429972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,26762,58,1.77 [1.22-2.57],0.0027883605115387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,26762,58,1.39 [1.01-1.90],0.0418855188001348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",26244,55,1.41 [1.09-1.81],0.0083131872839164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,26386,58,1.51 [1.03-2.20],0.033841715028889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,27014,59,1.75 [1.08-2.85],0.0235054403854865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,26662,58,2.41 [1.02-5.74],0.0459272946307253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,27167,58,2.38 [1.40-4.06],0.0013900678291635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,26709,59,2.39 [1.47-3.88],0.0004095537438841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,22791,40,2.29 [1.43-3.65],0.0005129617161231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,22791,40,2.30 [1.39-3.81],0.0012495502004126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,23449,42,3.02 [1.43-6.40],0.003845388139332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,26762,58,1.42 [1.09-1.87],0.0104377486356166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,27019,58,2.05 [1.12-3.75],0.0203402849452404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,26888,57,1.44 [1.04-2.01],0.0291001851265744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,22801,38,1.73 [1.25-2.40],0.0010274455396682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,22791,40,1.58 [1.18-2.13],0.0024103217263762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,27070,59,4.07 [1.40-11.81],0.0097197295820972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,26762,58,3.05 [1.10-8.41],0.0316117510737796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,25820,55,0.57 [0.34-0.93],0.0254369388684531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,25054,55,0.55 [0.34-0.92],0.021324630343205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,27107,59,2.33 [1.33-4.07],0.0030391155552726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,26935,58,2.12 [1.22-3.67],0.0075584312912779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,26244,55,1.59 [1.24-2.05],0.0003002041058133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,22509,42,1.52 [1.17-1.99],0.0018657487876052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,26762,58,1.69 [1.15-2.48],0.0079551257890814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27013,59,1.48 [1.05-2.08],0.0238346807609056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,26762,58,1.66 [1.09-2.54],0.018257159430352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,26762,58,1.58 [1.06-2.35],0.0244184662769442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,26244,55,1.52 [1.06-2.18],0.0236856869496255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,22720,41,1.95 [1.27-2.99],0.0021788731180993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,23331,41,1.69 [1.10-2.58],0.0159392578550352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,23501,41,1.64 [1.10-2.44],0.0161519709432444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,26244,55,1.56 [1.15-2.11],0.0042196502730283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,26703,58,0.45 [0.23-0.87],0.018152105711765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,22791,40,2.36 [1.46-3.83],0.0004726054727932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,27123,58,3.21 [1.06-9.78],0.0397378655212593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,22605,39,1.84 [1.29-2.61],0.0006821000289129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27122,59,2.89 [1.26-6.60],0.0119012991056503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,27122,59,1.57 [1.14-2.16],0.0052788864090838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,26837,59,1.97 [1.29-3.01],0.0016308082728514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,22605,39,1.95 [1.43-2.65],2.331135879523231e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,27030,58,3.32 [1.24-8.90],0.0173168359469833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,26974,59,1.69 [1.03-2.76],0.0369216209891323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,23501,41,7.61 [2.41-23.99],0.0005365475277298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,26171,58,1.50 [1.01-2.21],0.0420691042670891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,23501,41,4.48 [1.12-17.94],0.0338453449206771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,22934,41,3.83 [1.52-9.65],0.0044080844720989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,26762,58,2.19 [1.18-4.06],0.0130730440053268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,26811,58,1.43 [1.06-1.93],0.018534496376385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,26809,58,0.57 [0.40-0.82],0.0025352497530235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,26669,58,1.50 [1.05-2.14],0.0259386260629308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,26221,58,1.38 [1.05-1.81],0.0198778847032379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,23016,42,1.18 [1.03-1.35],0.0180902472545414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,26845,57,1.39 [1.03-1.87],0.0295318021758147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,27107,59,0.42 [0.21-0.83],0.0121653168379285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,23323,40,1.68 [1.11-2.54],0.0141575791289154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,23420,41,1.35 [1.03-1.77],0.0276167615216162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,27167,58,2.21 [1.19-4.10],0.012336335632586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,26796,59,1.62 [1.00-2.60],0.0487063192828249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,26641,58,1.58 [1.07-2.32],0.0202505406045799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,27019,58,2.28 [1.35-3.84],0.0019473833266797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,27167,58,2.09 [1.32-3.33],0.0017456660968243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,26755,59,1.55 [1.10-2.18],0.011549058124562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,26715,58,1.54 [1.11-2.12],0.0096170022862767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,27176,59,1.89 [1.03-3.45],0.0387587467121144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,26892,58,2.34 [1.34-4.08],0.002843128396175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,26300,59,2.26 [1.53-3.34],4.269274634062672e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,26973,57,2.01 [1.21-3.33],0.0069578588954459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,26703,58,2.62 [1.58-4.34],0.0001937950107599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,26892,58,3.30 [1.75-6.19],0.0002078793466318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,27122,59,2.00 [1.08-3.71],0.0271173174051677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,27012,59,1.86 [1.10-3.14],0.0205224895496364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,26762,58,2.31 [1.17-4.58],0.0165096231737163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,22791,40,2.28 [1.27-4.08],0.0057519460897168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,26890,58,1.55 [1.00-2.39],0.0479163184701962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,26976,58,2.30 [1.09-4.85],0.0284455644884596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,25899,58,2.44 [1.15-5.20],0.0202447073650959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,23366,41,2.15 [1.18-3.93],0.0124716482300741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,22742,40,1.98 [1.20-3.26],0.007076754161497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,22952,38,2.19 [1.17-4.10],0.0146775076576172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,27122,59,2.92 [1.66-5.14],0.0001914542757163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,27167,58,1.83 [1.16-2.87],0.0089668540846479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,26703,58,1.71 [1.13-2.59],0.0107008109783432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,26929,57,3.75 [1.34-10.50],0.0117615340990508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,26837,59,1.48 [1.16-1.88],0.0013733921894244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23449,42,2.35 [1.26-4.38],0.0074540269009866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,26386,58,1.78 [1.21-2.62],0.0035430286882167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,23449,42,0.61 [0.39-0.95],0.0273325213199151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,23057,41,2.87 [1.11-7.44],0.0299977834071403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23402,42,1.99 [1.09-3.63],0.0244061381392115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,23323,40,2.36 [1.39-3.99],0.0014255179859172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,26271,59,1.44 [1.11-1.86],0.0061931008768842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,26976,58,3.03 [1.49-6.18],0.0022564164749866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,27038,58,2.51 [1.24-5.09],0.0107678124835513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,26842,58,2.14 [1.33-3.43],0.0017306092740752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,26837,59,1.70 [1.19-2.41],0.0032948139473006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,26244,55,2.05 [1.33-3.17],0.0012148701398415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,27107,59,1.78 [1.09-2.89],0.0200368795717184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,26954,59,0.48 [0.26-0.90],0.0224879166853817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,26998,58,7.15 [2.83-18.04],3.128531713926604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,23331,41,2.19 [1.21-3.96],0.009606200904009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,26888,57,2.33 [1.36-4.00],0.0020873111601842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,27215,59,2.56 [1.48-4.45],0.0008259790013131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,23016,42,1.74 [1.27-2.39],0.0005487884046197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,26892,58,2.65 [1.16-6.09],0.0212306514681652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",26762,58,1.37 [1.01-1.85],0.0411607934588205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,26997,59,2.13 [1.18-3.85],0.0118167384491926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,23402,42,3.04 [1.27-7.28],0.0124692908731606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,26892,58,3.86 [1.69-8.80],0.0013220703786741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,26703,58,2.19 [1.46-3.28],0.0001379268575025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,26703,58,1.70 [1.09-2.64],0.0192189755732742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,27019,58,3.04 [1.42-6.52],0.0042294343354104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,22791,40,2.04 [1.04-3.99],0.0379351438939243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,22720,41,1.35 [1.07-1.70],0.0125464823110527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,26934,59,2.92 [1.44-5.90],0.0028536601133848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,26512,57,2.96 [1.93-4.53],6.192063639491866e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,26896,57,0.70 [0.49-0.99],0.046225622768295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,26888,57,3.35 [1.44-7.76],0.0048743288666828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,21096,44,3.79 [1.37-10.50],0.0104228230266473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,27030,59,0.56 [0.32-0.99],0.0466787060210749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,26880,58,2.10 [1.04-4.24],0.0396649492542945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,27019,58,1.59 [1.23-2.06],0.0004597933697694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,27122,59,1.37 [1.10-1.71],0.0052311852717901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,27122,59,1.50 [1.23-1.82],6.071843890874351e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,27167,58,1.81 [1.09-2.99],0.0217041149396218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,26656,59,1.37 [1.08-1.73],0.0093555842922529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,27019,58,1.68 [1.30-2.18],8.16660218697369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,22791,40,1.60 [1.19-2.15],0.0019631768404931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,22791,40,1.81 [1.09-3.01],0.0212587745444611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",26762,58,1.60 [1.02-2.51],0.0427913468690223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,22952,38,1.44 [1.01-2.06],0.0468351498043521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,27122,59,2.90 [1.16-7.24],0.0225323444939146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,26244,55,1.38 [1.01-1.90],0.0454342338028325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,26335,59,1.54 [1.11-2.12],0.0088525483206722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,26973,57,2.46 [1.18-5.12],0.0164756338702733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,22859,42,1.48 [1.00-2.17],0.0479473284222051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,26979,58,1.86 [1.24-2.80],0.0029125610407956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,26762,58,2.43 [1.13-5.27],0.0237795583052214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,26655,57,1.49 [1.00-2.21],0.0485369812823781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,27215,59,3.07 [1.15-8.20],0.0249437217405432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,27013,59,1.54 [1.12-2.11],0.0072106472287965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,26613,58,1.79 [1.02-3.14],0.0407896835888226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,23283,40,2.28 [1.32-3.93],0.0031558940670868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,26762,58,2.72 [1.24-5.97],0.0125589723298846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23456,41,1.47 [1.06-2.04],0.0198440600068412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,27107,59,2.48 [1.45-4.25],0.0008906078169906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,22859,42,3.09 [1.19-8.04],0.0207859534080084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,26662,58,2.24 [1.19-4.22],0.0128613680231766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,26837,59,1.36 [1.02-1.82],0.0382630383430268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,26888,57,1.54 [1.12-2.12],0.0076464142517161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,22859,42,1.65 [1.07-2.52],0.0223516200242602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,25935,55,1.99 [1.21-3.27],0.0064517891627763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,27215,59,2.82 [1.29-6.18],0.0094603504255877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23323,40,2.24 [1.41-3.54],0.0006123715923818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,22791,40,1.47 [1.02-2.10],0.0371911282160536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,23469,40,2.18 [1.13-4.22],0.02022505971043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,27036,59,1.57 [1.16-2.10],0.0029449288440984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,26845,57,2.33 [1.11-4.92],0.0260954787387762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,27129,59,1.61 [1.02-2.53],0.0393504469711544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,26837,59,1.71 [1.07-2.75],0.0260071668307726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,26244,55,1.37 [1.01-1.87],0.0431499149795296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",22720,41,1.75 [1.39-2.20],1.9579267411931394e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,22791,40,1.54 [1.06-2.23],0.0227820370117592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,27059,59,1.23 [1.01-1.49],0.0352579377061725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,27066,59,1.66 [1.26-2.18],0.0003019186621724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,22791,40,1.82 [1.09-3.05],0.0222630703387713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,22791,40,1.52 [1.10-2.09],0.0106338431815385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,23469,40,1.66 [1.04-2.66],0.0328328240077546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,26719,58,2.87 [1.42-5.82],0.0034581534246624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,26221,58,1.35 [1.08-1.70],0.009210658915216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,22791,40,1.26 [1.03-1.55],0.0253608633772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,26887,57,1.12 [1.01-1.24],0.0367561954583154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,26221,58,1.71 [1.25-2.34],0.0007502906742025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,26847,58,2.37 [1.24-4.54],0.0091828493827538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,26204,55,1.76 [1.09-2.84],0.0204899014021144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23323,40,1.80 [1.25-2.58],0.0014652921091224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,22605,39,1.37 [1.03-1.83],0.0307591234798682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,26762,58,2.73 [1.27-5.89],0.0104114454940174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,27036,59,5.28 [2.22-12.55],0.0001672917880481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,27215,59,2.30 [1.63-3.22],1.628671436478583e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,26888,57,2.26 [1.20-4.24],0.0111882850686282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,26204,55,2.05 [1.35-3.11],0.0007287273708198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,27059,59,5.18 [2.59-10.34],3.171672510451553e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,26850,57,1.70 [1.16-2.52],0.0072041345408047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,26703,58,1.85 [1.08-3.16],0.0250506180432768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,22791,40,2.16 [1.29-3.62],0.0034242245204295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,26386,58,1.84 [1.28-2.65],0.0009539507393233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",23449,42,1.88 [1.14-3.08],0.0129609435311179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,23323,40,1.80 [1.15-2.84],0.0105709511526365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,23331,41,1.72 [1.12-2.64],0.0130959575568532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,23323,40,1.69 [1.20-2.39],0.0028268474537131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",23420,41,1.64 [1.01-2.67],0.043675165920916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,26768,57,2.60 [1.04-6.53],0.0411201429340665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,27070,59,1.49 [1.06-2.10],0.0214361476322233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,26892,58,2.46 [1.40-4.34],0.0018143547483086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,27074,59,1.38 [1.09-1.75],0.007629632473436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,27167,58,2.76 [1.58-4.83],0.0003698825468745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,23402,42,1.52 [1.04-2.22],0.0309985466627776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,23359,42,1.71 [1.14-2.56],0.0100227349229266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,27107,59,1.79 [1.07-2.97],0.0258413561059321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,26221,58,1.50 [1.00-2.25],0.0479324637330927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,26979,58,1.41 [1.04-1.90],0.0246485082852979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,27107,59,2.12 [1.21-3.69],0.0084016198183852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,26709,59,2.98 [1.35-6.56],0.0066956171969984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,26758,59,2.15 [1.04-4.44],0.0385916799807409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,27215,59,2.17 [1.04-4.54],0.0394767856926521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,27215,59,3.15 [1.42-7.00],0.004912376742474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",22859,42,1.60 [1.16-2.21],0.004100705740903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,27107,59,2.53 [1.47-4.35],0.0007946445215853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,22756,41,3.00 [1.77-5.10],4.4452616893619216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,27170,59,1.66 [1.14-2.42],0.0087175951361953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,26531,56,2.11 [1.36-3.27],0.0008167805550318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,27215,59,2.94 [2.10-4.13],4.2656258500433966e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,26888,57,2.55 [1.40-4.63],0.0022172451777413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,23452,41,1.92 [1.14-3.22],0.0137262511848473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,26762,58,2.06 [1.27-3.35],0.0034935553685442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,26762,58,1.42 [1.10-1.85],0.0077325345282841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,27167,58,1.54 [1.03-2.31],0.0371917084147864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,26837,59,1.98 [1.09-3.59],0.0250643091331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,26806,58,1.57 [1.02-2.41],0.0386301314951115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,27167,58,2.01 [1.02-3.95],0.0427522049528685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,26845,58,1.58 [1.14-2.19],0.0059369374524607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,26345,55,1.47 [1.12-1.92],0.0051194889687953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,26837,59,1.68 [1.05-2.69],0.0294802733336925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,22699,40,1.43 [1.02-2.00],0.0393238008325914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,26837,59,2.25 [1.39-3.64],0.0009870883377097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,26345,55,1.19 [1.05-1.35],0.0072082300747149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,26837,59,1.68 [1.15-2.44],0.0068080691939187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,26707,59,2.27 [1.17-4.42],0.0153595349967008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,26892,58,0.63 [0.42-0.96],0.0334429098251574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,23323,40,1.65 [1.04-2.63],0.0330757021592476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,26837,59,0.47 [0.24-0.92],0.0267700887465502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,26837,59,1.56 [1.08-2.24],0.0171340194608381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,26244,55,1.96 [1.24-3.11],0.0040012349428381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,23449,42,2.59 [1.40-4.77],0.0023473334281676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,26837,59,1.66 [1.14-2.40],0.0074561865260881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,27122,59,2.45 [1.13-5.28],0.0226554561680913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,26221,58,0.52 [0.28-0.97],0.0405703476179306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,22959,41,1.78 [1.16-2.72],0.0078363485804036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,23402,42,2.24 [1.14-4.40],0.0190415310723103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,22691,40,1.98 [1.14-3.44],0.0155389165784105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",26798,59,1.49 [1.12-1.99],0.0066658817585195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,26892,58,2.04 [1.31-3.19],0.0017399966582908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,26074,56,6.62 [1.83-23.93],0.0039406731177583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,27122,59,1.32 [1.00-1.73],0.0471711043078919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,23456,41,1.68 [1.14-2.46],0.0082254552742821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,26888,57,2.05 [1.11-3.79],0.0213473424118898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,23501,41,2.08 [1.13-3.84],0.0191333104933141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,26892,58,1.54 [1.03-2.28],0.034580300946575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,26890,58,2.55 [1.34-4.83],0.0042138234860029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,27019,58,2.36 [1.29-4.29],0.005061233869904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,26244,55,1.28 [1.03-1.60],0.0254251257137289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,22720,41,1.49 [1.01-2.20],0.0451887378829178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,26345,55,1.78 [1.07-2.96],0.0271761095117265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,23285,41,1.57 [1.15-2.15],0.0043658435574409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,26061,57,1.44 [1.00-2.07],0.0478980442596264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,22702,40,2.05 [1.10-3.82],0.0235064042293888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23331,41,2.01 [1.01-3.99],0.0472263793586835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,26837,59,1.72 [1.01-2.93],0.044092224271877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,27215,59,2.53 [1.30-4.92],0.0062605544993632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,26703,58,2.14 [1.30-3.51],0.0026227707229246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,26609,58,1.51 [1.12-2.05],0.0071500392058072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,26941,58,3.10 [1.45-6.61],0.0033841875861692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,22791,40,1.41 [1.06-1.89],0.0185060989971774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,26898,57,1.60 [1.23-2.09],0.0005031825407305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,27167,58,3.47 [1.60-7.51],0.0015744535901036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,22791,40,1.68 [1.06-2.65],0.0257933680071457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,26339,58,2.59 [1.59-4.22],0.0001226634350875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,27076,59,1.40 [1.04-1.88],0.0272150662142145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,26850,58,1.57 [1.07-2.31],0.0212625165182021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",22720,41,1.68 [1.05-2.69],0.0289928941380714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,26847,57,1.30 [1.10-1.54],0.0025654287036174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",22566,39,2.97 [1.21-7.26],0.0171118279024195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23420,41,1.37 [1.02-1.84],0.0383216419107847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,26386,58,0.55 [0.35-0.87],0.0107738377036883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,22952,38,0.38 [0.15-0.99],0.0472399432644359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",22859,42,1.31 [1.03-1.65],0.0255044828526532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,26984,58,1.54 [1.02-2.33],0.0387303170088582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,22742,40,1.49 [1.05-2.11],0.0274169640274182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,26244,55,1.43 [1.07-1.89],0.0139300719698805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,26802,59,1.31 [1.06-1.63],0.012576689935184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,27107,59,2.72 [1.24-5.98],0.0128708622112509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,26845,57,2.78 [1.35-5.71],0.0053597701296945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,22791,40,1.98 [1.14-3.42],0.0149388484538743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,26135,57,1.96 [1.24-3.11],0.0041557536688217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,22394,37,4.31 [1.54-12.08],0.0053939930908858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,26882,59,1.83 [1.07-3.15],0.0281125243676021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,26703,58,1.30 [1.02-1.65],0.031456305822318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",26221,58,1.48 [1.07-2.03],0.0162918047186164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,23056,42,2.22 [1.23-4.02],0.0085191129468851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,26888,57,2.59 [1.44-4.69],0.0015984795417402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,23456,41,2.03 [1.16-3.54],0.0125790577679741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,27021,59,2.17 [1.02-4.64],0.0450586179543192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,27122,59,1.47 [1.06-2.05],0.0227678761076303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,23402,42,2.13 [1.34-3.37],0.0013896901823465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,26973,57,1.48 [1.05-2.08],0.0264909841414352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,23289,41,1.43 [1.02-1.99],0.0357961547725704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,23420,41,2.21 [1.27-3.82],0.0047348506280813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,26892,58,1.79 [1.06-3.01],0.0288712825276729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,26627,57,1.42 [1.01-1.99],0.0430722425473902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,22691,40,1.64 [1.10-2.44],0.0150347938814744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,23421,41,5.77 [1.63-20.49],0.0066501685018731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,26941,58,2.26 [1.13-4.51],0.0213278910156414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,26712,59,1.43 [1.04-1.96],0.0284996918128774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,23402,42,2.46 [1.35-4.49],0.003295782912223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,27070,59,3.51 [1.42-8.66],0.0065352196616979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,26888,57,2.05 [1.11-3.81],0.0222135085015593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,27215,59,1.91 [1.07-3.42],0.0284047078332864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,27122,59,1.57 [1.08-2.28],0.0171827562713223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,26888,57,2.16 [1.27-3.65],0.0042036197289292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,27215,59,0.51 [0.27-0.96],0.0357507111799193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,22952,38,2.16 [1.38-3.39],0.0007392361667057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,22791,40,2.06 [1.28-3.31],0.0029853005139984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,26892,58,1.50 [1.03-2.18],0.0340046380982678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,27167,58,2.80 [1.51-5.18],0.001030827873858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,27084,59,1.99 [1.28-3.09],0.0020706477422109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,22791,40,1.25 [1.01-1.56],0.0418625675716546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,26546,57,2.90 [1.64-5.13],0.0002461874514723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,26892,58,2.27 [1.31-3.95],0.0036895990875712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,26888,57,1.68 [1.07-2.62],0.0230575523670567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,22720,41,1.73 [1.15-2.59],0.0078824763592246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,26936,58,1.46 [1.08-1.98],0.014678767052019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,26973,57,3.70 [1.65-8.31],0.0014915986825699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,27129,59,1.81 [1.15-2.86],0.0107315297750822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,26892,58,1.66 [1.08-2.54],0.0202948027276735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,26727,58,5.46 [2.61-11.43],6.46840704092852e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",22791,40,1.91 [1.39-2.63],6.614935275426966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,22889,41,2.99 [1.20-7.48],0.0191798433189059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,27120,59,0.47 [0.25-0.87],0.0159686913199875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,27088,59,2.86 [1.14-7.15],0.0245654590629775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,22791,40,2.01 [1.09-3.71],0.024436134475525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,22791,40,2.33 [1.43-3.77],0.0006263443540539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,26762,58,1.65 [1.14-2.40],0.0076635628777449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,26892,58,2.72 [1.01-7.28],0.0468053726845833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,23449,42,1.77 [1.05-2.96],0.0306845203898709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,26837,59,1.57 [1.12-2.20],0.0082116285930635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,22791,40,1.82 [1.26-2.62],0.0013280739109961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,22791,40,1.86 [1.26-2.75],0.0017260591904704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,26191,57,1.48 [1.00-2.20],0.0486705955368696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,23016,42,2.06 [1.27-3.36],0.0036093509213684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,23228,42,2.15 [1.10-4.24],0.0261215887134238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,23331,41,1.17 [1.02-1.34],0.0278018861977808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,26762,58,1.51 [1.05-2.15],0.0247207634587793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,26577,57,2.09 [1.14-3.81],0.0163144172360255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,26837,59,1.64 [1.09-2.46],0.017025328204558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,22600,40,1.78 [1.08-2.95],0.0239739456890645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,26386,58,1.62 [1.05-2.49],0.0280755145192498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,22747,40,1.74 [1.03-2.96],0.0387794513243675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,27122,59,2.78 [1.72-4.52],3.400652883165949e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,26926,59,2.88 [1.51-5.52],0.0013715495064247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,22801,38,1.34 [1.00-1.79],0.0464398692523249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,22791,40,1.41 [1.10-1.80],0.0061288509944849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,27021,59,1.63 [1.07-2.48],0.0232447517186754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,26244,55,1.51 [1.17-1.96],0.0014341605584388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,23420,41,2.04 [1.37-3.05],0.0004546085838933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,26255,58,1.59 [1.04-2.44],0.0324078767485316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,26941,58,2.06 [1.38-3.09],0.0004479797071209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,26892,58,2.36 [1.12-4.98],0.0233650402248783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,26888,57,1.65 [1.31-2.08],2.363968295866856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,26345,55,0.43 [0.23-0.80],0.0077929586825498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,27022,59,1.49 [1.04-2.15],0.030945919614529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,23298,40,1.90 [1.09-3.32],0.0233711516369208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,22791,40,1.87 [1.13-3.08],0.0144627922296428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,26941,58,2.36 [1.01-5.51],0.0468695240278292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,22791,40,2.01 [1.04-3.89],0.0370538861294616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,26703,58,2.20 [1.37-3.53],0.0011107950445566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,27107,59,2.62 [1.37-5.01],0.0035167344598858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,26665,57,1.53 [1.09-2.15],0.0138028650263192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,26521,58,1.34 [1.01-1.80],0.0448790622902049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,23323,40,1.52 [1.04-2.22],0.0324082343068691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,26973,57,1.52 [1.00-2.31],0.0475817597707257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,22720,41,1.68 [1.10-2.56],0.0163706114284585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,26205,57,2.70 [1.53-4.76],0.0006281776394885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,27122,59,2.41 [1.15-5.08],0.0203203501967071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,26837,59,0.48 [0.25-0.90],0.023293914619959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,26762,58,2.39 [1.70-3.37],5.789856289498485e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,23016,42,1.42 [1.03-1.97],0.0312908256871753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,23053,41,22.09 [2.84-171.97],0.0031149552457482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,27215,59,2.58 [1.43-4.64],0.0015858915558849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,27167,58,1.45 [1.10-1.90],0.0084629857939078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,23055,41,6.71 [1.02-44.16],0.0478284286595816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,23450,41,5.22 [1.09-24.92],0.0383735529217662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,26622,58,2.12 [1.51-2.98],1.630440216448846e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,26244,55,1.57 [1.06-2.32],0.0236133319262182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,22691,40,1.45 [1.05-2.02],0.0262257524316505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,22893,42,1.46 [1.06-2.02],0.0207506345556592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,23449,42,2.72 [1.41-5.26],0.0028860573661453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,26837,59,2.10 [1.14-3.90],0.0179095646101368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,22859,42,2.34 [1.26-4.36],0.0073943628569877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,27070,59,2.26 [1.01-5.02],0.0464243866873463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,26762,58,1.31 [1.01-1.70],0.0453710192004568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,26837,59,1.53 [1.06-2.22],0.0237467322456171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,26244,55,2.29 [1.55-3.39],3.3623399796976815e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,22801,38,1.62 [1.13-2.32],0.0093477707497248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,23331,41,1.47 [1.07-2.01],0.0173589014117912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,27107,59,2.13 [1.10-4.12],0.0248650415326788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,27019,58,1.95 [1.12-3.42],0.0192468370201987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,26993,59,1.75 [1.12-2.73],0.0147607657005454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,22791,40,1.57 [1.14-2.17],0.0063568394474665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,26979,58,1.56 [1.06-2.29],0.0244164484962589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,22691,40,1.84 [1.01-3.35],0.0456145650234534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,26703,58,1.70 [1.20-2.42],0.002903225609523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",26892,58,1.89 [1.15-3.13],0.0125644419365763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,23469,40,0.44 [0.23-0.85],0.0148256019721524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,26811,57,2.48 [1.09-5.67],0.0305688215436451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,26941,58,2.29 [1.43-3.67],0.0005500849588517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,26761,57,3.45 [1.90-6.28],4.813641267023224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",27215,59,2.85 [1.39-5.85],0.0043477745599121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",22791,40,1.90 [1.37-2.62],0.0001047000597401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,23449,42,2.77 [1.23-6.20],0.0134157667734732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,27122,59,1.70 [1.03-2.78],0.0360720838908998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,26244,55,1.45 [1.05-2.01],0.0254907689330806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,26762,58,1.40 [1.03-1.90],0.0328640718069076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,22791,40,1.72 [1.18-2.50],0.0048744616673769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,26837,59,1.55 [1.01-2.38],0.0436435814659753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,26244,55,1.64 [1.06-2.53],0.0248815395616139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,26837,59,1.45 [1.05-1.99],0.0224004839184909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,26762,58,2.38 [1.34-4.20],0.0029209953070637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,27170,59,2.24 [1.38-3.64],0.0011674593154228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,26843,59,1.49 [1.02-2.18],0.0409946998135661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,26885,56,1.50 [1.04-2.15],0.0290346410490893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,26837,59,1.60 [1.04-2.48],0.0335181526268357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,27123,58,2.06 [1.19-3.56],0.0095877066125361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,26845,57,1.39 [1.03-1.87],0.0302773938816136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,26763,57,2.04 [1.04-4.00],0.0386613819739017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,27122,59,2.41 [1.15-5.07],0.0203903006213174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,26567,59,2.91 [1.58-5.35],0.0005952148616861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,26796,57,3.45 [1.24-9.57],0.0175431966500403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,22791,40,2.47 [1.06-5.73],0.0356442493627244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,26892,58,1.47 [1.09-2.00],0.0127594582692871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,26703,58,2.26 [1.53-3.36],4.684107654323577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,26703,58,1.45 [1.11-1.90],0.006286872789504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,26892,58,2.87 [1.44-5.70],0.0027401442088966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,26973,57,2.18 [1.19-3.98],0.0115333900277123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,26941,58,2.15 [1.38-3.34],0.0006492037198655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,26941,58,2.35 [1.17-4.72],0.0165762461564045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27107,59,2.02 [1.06-3.83],0.0323878227876316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,26892,58,2.65 [1.38-5.11],0.003534549742214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,26892,58,1.55 [1.06-2.28],0.0239886695326856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,26703,58,1.48 [1.04-2.10],0.02917083453913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27122,59,1.59 [1.02-2.49],0.0411841321338442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,27170,59,2.14 [1.23-3.75],0.007412462606716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,26703,58,0.50 [0.30-0.84],0.0090237535047367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,22454,36,1.77 [1.02-3.09],0.0431644509636166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,26723,58,1.70 [1.16-2.49],0.0065817024617229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,27120,58,2.09 [1.33-3.28],0.0013618603798641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,23079,39,1.76 [1.19-2.61],0.0050214926478934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,26762,58,1.94 [1.03-3.64],0.0409693656165363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23456,41,1.64 [1.04-2.60],0.03323807848949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,22791,40,1.61 [1.11-2.32],0.0110726135297747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,26703,58,1.87 [1.07-3.27],0.0290000256088891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23402,42,1.93 [1.22-3.05],0.0050599912777264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,22791,40,1.39 [1.00-1.94],0.0497294809624772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,22791,40,5.71 [2.33-14.00],0.0001375914850675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,26762,58,2.26 [1.26-4.03],0.0058759487504451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,23323,40,1.97 [1.35-2.87],0.0004027223875629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,26386,58,0.62 [0.39-0.97],0.0366034932022038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",26892,58,1.83 [1.02-3.29],0.0444374718729869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,25492,54,2.36 [1.46-3.83],0.0004773025978668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,26345,55,1.94 [1.04-3.62],0.0374688207428598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,27107,59,1.43 [1.04-1.96],0.0283496159967356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,27080,59,2.01 [1.12-3.61],0.020031301779558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,26973,57,0.68 [0.53-0.89],0.0041765131291281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,23402,42,2.70 [1.10-6.64],0.0302103584564573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,22720,41,1.62 [1.04-2.53],0.0313286458328992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,26386,58,1.58 [1.06-2.35],0.0255536143877047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23323,40,1.59 [1.02-2.47],0.0397624444989186
